Steris (STE) Net Income towards Common Stockholders Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 30.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 99.49% |
| Dec 31, 2024 | 98.69% |
| Sep 30, 2024 | 95.51% |
| Jun 30, 2024 | 182.46% |
| Mar 31, 2024 | -3,338.22% |
| Dec 31, 2023 | 0.29% |
| Sep 30, 2023 | 98.99% |
| Jun 30, 2023 | 18.48% |
| Mar 31, 2023 | -94.91% |
| Dec 31, 2022 | -105.37% |
| Sep 30, 2022 | -730.72% |
| Jun 30, 2022 | 61.97% |
| Mar 31, 2022 | -25.28% |
| Dec 31, 2021 | 24.88% |
| Sep 30, 2021 | -34.32% |
| Jun 30, 2021 | -124.46% |
| Mar 31, 2021 | 13.48% |
| Dec 31, 2020 | -14.46% |
| Sep 30, 2020 | 11.42% |
| Jun 30, 2020 | 5.94% |
| Mar 31, 2020 | 9.83% |
| Dec 31, 2019 | 176.61% |
| Sep 30, 2019 | 22.77% |
| Jun 30, 2019 | 20.25% |
| Mar 31, 2019 | -64.22% |
| Mar 31, 2018 | 2,558.45% |